The influence of calcium on the antilipolytic action of propranolol, timolol, labetalol, verapamil, procaine, and papaverine in rat adipocytes.
D000273:Adipose Tissue / Q000166:cytology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D007741:Labetalol / Q000494:pharmacology; D008066:Lipolysis / Q000187:drug effects*; D008297:Male; D010208:Papaverine / Q000494:pharmacology; D011343:Procaine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013999:Timolol / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents; D011343:Procaine; D013999:Timolol; D000324:Adrenocorticotropic Hormone; D011433:Propranolol; D014700:Verapamil; D010208:Papaverine; D007545:Isoproterenol; D007741:Labetalol; D002118:Calcium